Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

450 ARTíCULOS , VIENDO DEL 421 AL 435

PUBMED

The neuropsychiatric manifestations of Huntington's disease-like 2.

Fischer CA, Licht EA, Mendez MF.

J Neuropsychiatry Clin Neurosci. 2012 Fall;24(4):489-92. doi: 10.1176/appi.neuropsych.11120358.

0

0

0

PUBMED

A novel BACHD transgenic rat exhibits characteristic neuropathological features of Huntington disease.

Yu-Taeger L, Petrasch-Parwez E, Osmand AP, Redensek A, Metzger S, Clemens LE, Park L, Howland D, Calaminus C, Gu X, Pichler B, Yang XW, Riess O, Nguyen HP.

J Neurosci. 2012 Oct 31;32(44):15426-38. doi: 10.1523/JNEUROSCI.1148-12.2012.

0

0

0

PUBMED

Statistical characteristics of finger-tapping data in Huntington's disease.

Antoniades CA, Ober J, Hicks S, Siuda G, Carpenter RH, Kennard C, Nemeth AH.

Med Biol Eng Comput. 2012 Apr;50(4):341-6. doi: 10.1007/s11517-012-0863-2.

0

0

0

PUBMED

Msh2 acts in medium-spiny striatal neurons as an enhancer of CAG instability and mutant huntingtin phenotypes in Huntington's disease knock-in mice.

Kovalenko M, Dragileva E, St Claire J, Gillis T, Guide JR, New J, Dong H, Kucherlapati R, Kucherlapati MH, Ehrlich ME, Lee JM, Wheeler VC.

PLoS One. 2012;7(9):e44273. doi: 10.1371/journal.pone.0044273.

0

0

0

PUBMED

Development of the Huntington disease work function scale.

Brossman B, Williams JK, Downing N, Mills JA, Paulsen JS; PREDICT-HD Investigators and Coordinators of the Huntington Study Group..

J Occup Environ Med. 2012 Oct;54(10):1300-8. doi: 10.1097/JOM.0b013e31825f30ab.

0

0

0

PUBMED

Putting proteins in their place: palmitoylation in Huntington disease and other neuropsychiatric diseases.

Young FB, Butland SL, Sanders SS, Sutton LM, Hayden MR.

Prog Neurobiol. 2012 May;97(2):220-38. doi: 10.1016/j.pneurobio.2011.11.002. Review.

0

0

0

PUBMED

Gene therapy for Huntington's disease.

Ramaswamy S, Kordower JH.

Neurobiol Dis. 2012 Nov;48(2):243-54. doi: 10.1016/j.nbd.2011.12.030. Review.

0

0

0

PUBMED

ATRX induction by mutant huntingtin via Cdx2 modulates heterochromatin condensation and pathology in Huntington's disease.

Lee J, Hong YK, Jeon GS, Hwang YJ, Kim KY, Seong KH, Jung MK, Picketts DJ, Kowall NW, Cho KS, Ryu H.

Cell Death Differ. 2012 Jul;19(7):1109-16. doi: 10.1038/cdd.2011.196.

0

0

0

PUBMED

Drosophila eye color mutants as therapeutic tools for Huntington disease.

Green EW, Campesan S, Breda C, Sathyasaikumar KV, Muchowski PJ, Schwarcz R, Kyriacou CP, Giorgini F.

Fly (Austin). 2012 Apr-Jun;6(2):117-20. doi: 10.4161/fly.19999.

0

0

0

PUBMED

Memory deficits in the transgenic rat model of Huntington's disease.

Zeef DH, van Goethem NP, Vlamings R, Schaper F, Jahanshahi A, Hescham S, von Hörsten S, Prickaerts J, Temel Y.

Behav Brain Res. 2012 Feb 1;227(1):194-8. doi: 10.1016/j.bbr.2011.11.009.

0

0

0

PUBMED

Chorea in primary antiphospholipid syndrome is associated with rheumatic fever.

Appenzeller S, Yeh S, Maruyama M, Barros SM, de Carvalho JF.

Rheumatol Int. 2012 Sep;32(9):2857-61. doi: 10.1007/s00296-011-2120-7.

0

0

0

PUBMED

R6/2 Huntington's disease mice develop early and progressive abnormal brain metabolism and seizures.

Cepeda-Prado E, Popp S, Khan U, Stefanov D, Rodríguez J, Menalled LB, Dow-Edwards D, Small SA, Moreno H.

J Neurosci. 2012 May 9;32(19):6456-67. doi: 10.1523/JNEUROSCI.0388-12.2012.

0

0

0

PUBMED

RNAi-based therapies for Huntington's disease: delivery challenges and opportunities.

Mantha N, Das SK, Das NG.

Ther Deliv. 2012 Sep;3(9):1061-76. Review.

0

0

0

PUBMED

Protein misfolding detected early in pathogenesis of transgenic mouse model of Huntington disease using amyloid seeding assay.

Gupta S, Jie S, Colby DW.

J Biol Chem. 2012 Mar 23;287(13):9982-9. doi: 10.1074/jbc.M111.305417.

0

0

0

PUBMED

Discovery and structure-activity relationship of potent and selective covalent inhibitors of transglutaminase 2 for Huntington's disease.

Prime ME, Andersen OA, Barker JJ, Brooks MA, Cheng RK, Toogood-Johnson I, Courtney SM, Brookfield FA, Yarnold CJ, Marston RW, Johnson PD, Johnsen SF, Palfrey JJ, Vaidya D, Erfan S, Ichihara O, Felicet

J Med Chem. 2012 Feb 9;55(3):1021-46. doi: 10.1021/jm201310y.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy